Basel Saber: New Evidence on Stroke Prevention in Post-Operative Atrial Fibrillation
Basel Saber, Medical Student and LLMs Trainer at DataAnnotation, shared a post on LinkedIn about a recent article by Mazen Negmeldin Yassin et al, posted in European Stroke Journal, adding:
”I’m pleased to share that our work has been published in the European Stroke Journal as part of the European Stroke Organisation Conference proceedings.
Our abstract, ‘Can direct oral anticoagulants replace warfarin for stroke prevention in new-onset post-operative atrial fibrillation? A meta-analysis and trial sequential analysis,’ explores an important clinical question in optimizing anticoagulation strategies.”
Title: Abstract Number: ESOC2026A2118. Can Direct Oral Anticoagulants Replace Warfarin for Stroke Prevention in New-Onset Post-Operative Atrial Fibrillation? A Meta-Analysis and Trial Sequential Analysis
Authors: Mazen Negmeldin Yassin, Zeyad Bady, Ahmed Talkhan, Mohammad Al Diab Al Azzawi, Mahmoud Mohamed Lasheen, Muhammad Youssef, Basma Kamel, Basel Ayoub, Mahmoud Refaey, Mahmoud Mohamed, Yusof M Omar, Ahmed Nasreldein
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy